Skip to main content
Premium Trial:

Request an Annual Quote

Biodesix Closes $8.3M Financing Round

NEW YORK (GenomeWeb News) – Biodesix today said that it has closed an $8.3 million Series E round of private financing.

The Boulder, Colo.-based molecular diagnostics firm said that new funds accounted for $4.3 million of the financing round, while the remaining $4 million came from the conversion of a convertible note. It said that all of the funds came from existing shareholders in the firm.

Biodesix plans to use the funding to support ongoing development of its technology platform and to expand sales and marketing efforts for its first product, the VeriStrat proteomic biomarker test, which is intended to help physicians guide therapy for patients with advanced non-small cell lung cancer.

In June the firm announced that it had secured Medicare coverage for the VeriStrat test.

The Scan

Billion-Dollar Diversity Initiative

The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce.

Biotech Co-Founder Arrested

A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News.

Return of the Tasmanian Tiger

The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction.

Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More

In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.